GRcalculator: an online tool for calculating and mining dose-response data.

BMC Cancer · 2017 · PMC5655815 · PMID 29065900

Europe PMC DOI

hedged sentence

0.0033

closest p · 0.1× alpha

0.0033

boldest claim

The sentences

highly significantp = 0.0033actually significant

We see by the GR 50 metric that PTEN mutant and wild-type breast cancer cells exhibit a highly significant difference ( p = 0.0033) in sensitivity to lapatinib treatment, which is not found by IC 50 value ( p = 0.12; Step 9).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.